Workshops - Day 2
The Connect in Pharma workshops deliver high quality and technical content designed in collaboration with world-leading organisations.
10:00 - 10:45
Körber pharma ecosystem - delivering the difference in pharma manufacturing!
The workshop will focus on explaining and understanding the ecosystem of Körber Pharma, including some entertaining details about Körber Pharma expertise and explaining why and how it delivers the difference in pharma manufacturing.
The workshop will be an interactive platform for our audience and participants to explore Körber as a brand and its expertise in Pharma machinery, visual inspection machines, software, materials for pharma packaging and consulting in pharma manufacturing including topics such as Pharma 4.0, vertical and horizontal integration and best practices.
Let’s buckle up and prepare to soar through the skies to explore the world of Körber!
11:10 - 11:55
Direct API filling, advantages of a new trend
At Harro Höfliger we see the trend of direct API filling with solid powders for the development phase and beyond. Under direct API filling, we understand that there is no need for any additional blending process with excipients. Special technology from Harro Höfliger enables you to dose poor flowing powders.
12:00 - 12:45
Reducing your time to market of Injectable drug delivery containment in collaborating early in clinical stage
Wenzel Novak PhD, Senior Global Director Business Development MDS, Gerresheimer
Jean-Edouard Rabier, Project Management Director & Sales Development Gx Biological Solutions, Gerresheimer
Euroject®: an innovative BFS-based device for single dose injection of therapeutics
Recent innovations have opened up the possibility of using BFS technology to design aseptic packaging systems combining the efficiency of high-throughput production with the highest guarantees of sterility. The result is a new type of pre-filled, single-dose disposable device that can be produced in very large numbers with a high-speed rotary machine, at very low production costs. Euroject® can contribute to greater equity in access to new vaccines and to ensuring safe vaccine administration, while being simple and cost effective.
Alexandre Fontayne , Chief Scientist Officer for Biological products, Unither Pharmaceuticals
14:50 - 15:05
The market and regulatory trends for CMOs; a case study
Developing a biologics? Select the right partner to get your product to market faster
Choosing the right partner to help get your biologic to the market is critical to its success. It’s important to work with an experienced manufacturing partner that can adapt to your needs and grow with your program. From process development to packaging and everything in between, your partner should have the supply-chain network and scale-up experience to take your product through the clinic and into commercial launch, faster.
Andrea Como, VP, Head of Drug Product, Europe, Catalent